2021
DOI: 10.4269/ajtmh.21-0681
|View full text |Cite
|
Sign up to set email alerts
|

Chagas Disease in HIV-Infected Patients: It’s Time to Consider the Diagnosis

Abstract: This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provide the original author and source are credited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…To ensure prompt treatment, physician awareness of Chagas disease should also be increased, to minimize misinformation surrounding Chagas disease. [43][44][45] For example, in this investigation, one donor reported being told no treatment was available, and another was informed that local triatomines were not infected with T. cruzi despite contrary scientific evidence. 20 Serologic discrepancies remain a prominent hindrance for Chagas disease.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…To ensure prompt treatment, physician awareness of Chagas disease should also be increased, to minimize misinformation surrounding Chagas disease. [43][44][45] For example, in this investigation, one donor reported being told no treatment was available, and another was informed that local triatomines were not infected with T. cruzi despite contrary scientific evidence. 20 Serologic discrepancies remain a prominent hindrance for Chagas disease.…”
Section: Discussionmentioning
confidence: 94%
“…Thus, positive donors would also benefit from enhanced notification letters with recommendations for physician follow‐up. To ensure prompt treatment, physician awareness of Chagas disease should also be increased, to minimize misinformation surrounding Chagas disease 43–45 . For example, in this investigation, one donor reported being told no treatment was available, and another was informed that local triatomines were not infected with T. cruzi despite contrary scientific evidence 20 …”
Section: Discussionmentioning
confidence: 98%
“…Despite sustaining "hundreds" of bites from triatomines over a 10-year period, frequently finding them inside his home, and evidence of T. cruzi-infected triatomines collected from inside the home, our patient did not have clinical or serological evidence of chronic CD. There has been some concern that certain T. cruzi DTU strains found within certain geographic regions in Mexico, as well as Central and South America, have discordant serological testing results [29][30][31][32]. The sensitivity and specificity of our available CD serological tests have not been assessed among those with autochthonous CD in the US at this time.…”
Section: Discussionmentioning
confidence: 99%
“…In approximately 30% of patients, this cellular damage cycle cryptically continues at an accelerated pace until advanced disease clinically manifests. The factors that contribute to pathogenesis and reactivation are largely unknown but are hypothesized to correlate with parasite discrete typing unit [ 48 , 49 , 50 ], high-fat diets [ 51 , 52 ], co-infections [ 53 , 54 ], and host immunogenetics [ 55 ]. Murine models indicate three potential pathogenic pathways collectively, independently, or in verse contribute to cellular damage: autoimmune, neurogenic, or pro-inflammatory damage mediated by certain cytokines such as interleukin (IL)-6 and IL-17 [ 3 , 46 , 56 , 57 , 58 , 59 , 60 , 61 ].…”
Section: Oral T Cruzi Transmission Pathogenicitymentioning
confidence: 99%